CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017)

Size: px
Start display at page:

Download "CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017)"

Transcription

1 CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 4/27/2017) Leukemia AALL0932 closed after Induction Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy) AALL1131 A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# ) in the Very High Risk Stratum AALL1231 A Phase III Randomized Trial Investigating Bortezomib (NSC# ; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy) AALL1331 Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse of Childhood B- Lymphoblastic Leukemia AAML1031 A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# , NSC# ) for Patients with High Allelic Ratio FLT3/ITD FLT3 Negative withdraws after induction AAML1331 A Phase III Study for Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APL) using Arsenic Trioxide and All-Trans Retinoic Acid AAML1522 A Phase II, Multi-Center, Single-Arm, Open-Label Study to Evaluate the Activity, Safety and Pharmacokinetics of Lenalidomide (Revlimid) in Pediatric Subjects From 1 to 18 Years of Age with Relapsed or Refractory Acute Myeloid Leukemia AALL1521 POETIC POETIC A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitnib with Chemotherapy in Children with De Novo High-Risk CRLF2-Rearranged and/or Pathway-Mutant Acute Lymphoblastic Leukemia A Phase I/II Study of Neratinib in children and Pediatric Patients with Relapsed or Refractory Solid Tumors or Hematologic Malignancies Phase I Study of Carfilzomib in Combination with Cyclophosphamide and Etoposide for Children with Relapsed and Refractory Solid Tumors and Leukemias Page 1 of 6

2 Brain ACNS0332 ACNS0831 NMTRC 011 NMTRC ONC POETIC G POETIC Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients (closed to PNET patients) Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years Molecular-Guided Therapy for the Treatment of Patients with Relapsed and Refractory Childhood Cancers Eligible Diagnoses: Medulloblastomas, Gliomas, Diffuse Intrinsic Pontine Glioma/DIPG/Diffuse Midline Tumor, Glioblastoma Multiforme, Ependymomas, Choroid Plexus Tumors, Craniopharyngiomas, Dysembryoplastic neuroepithelial tumors, Meningiomas, Primitive Neuroectodermal Tumors/CNS Embryonal Tumors, Germ Cell Tumors and Atypical Teratoid Rhabdoid Tumor A Phase I Trial of Tolcapone Alone and in Combination with Oxaliplatin in Patients with Relapsed or Refractory Neuroblastoma or Medulloblastoma A Two-Part Study of TB-403 in Pediatric Subjects with Relapsed or Refractory Medulloblastoma, Neuroblastoma, Ewing Sarcoma, or Alveolar Rhabdomyosarcoma A Phase I/II Multicenter, Open Label, Dose Escalation Study Of The Safety And Pharmacokinetics Of Cobimetinib In Pediatric And Young Adult Patients With Previously Treated Solid Tumors Eligible Diagnoses: Central Nervous System Gliomas (including high and low grade gliomas and DIPG), Atypical Teratoid/Rhabdoid Tumor (ATRT), and Schwannoma Young Adult Patients with Previously Treated Solid Tumors Eligible Diagoses: Atypical Teratoid/Rhabdoid Tumor (ATRT) only A Phase I/II Study of Neratinib in children and Pediatric Patients with Relapsed or Refractory Solid Tumors or Hematologic Malignancies Eligible Diagnoses: Any Central Nervous System Malignancy Liver AHEP0731 Treatment of Children with All Stages of Hepatoblastoma (observation/very low risk only) Long Term Effects ALTE11C2 Health Effects after Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related Cardiomyopathy Page 2 of 6

3 Lymphoma AALL0932 AALL1231 AHOD1331 ALTE11C1 Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy) A Phase III Randomized Trial Investigating Bortezomib (NSC# ; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy) A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (chl) in Children and Adolescents Longitudinal Assessment of Ovarian Reserve in Adolescents with Lymphoma POETIC currently closed for lymphoma patients C25004 A Phase I/II Study of Neratinib in children and Pediatric Patients with Relapsed or Refractory Solid Tumors or Hematologic Malignancies Young Adult Patients with Previously Treated Solid Tumors - Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma An Open-Label Study of Brentuximab Vedotin+Adriamycin, Vinblastine, and Dacarbazine in Pediatric Patients With Advanced Stage Newly Diagnosed Hodgkin Lymphoma Page 3 of 6

4 Neuroblastoma ANBL1232 Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma ANBL1221 A Phase II Randomized Trial of Irinotecan/Temozolomide with Temsirolimus (NSC# , IND# 61010) or Chimeric Antibody(ch14.18 (NSC# , IND# 4308) in Children with Refractory, Relapsed or Progressive Neuroblastoma Molecular-Guided Therapy for the Treatment of Patients with Relapsed and Refractory Childhood Cancers NMTRC 010B NMTRC 012 NMTRC 014 NMTRC ONC A Phase I/II Trial of DFMO in Combination with Bortezomib in Patients with Relapsed or Refractory Neuroblastoma A Pilot Study Using Molecular Guided Therapy with Induction Chemotherapy Followed by Maintenance with DFMO for Subjects with Newly Diagnosed High-Risk Neuroblastoma Neuroblastoma Maintenance Therapy Trial Using DFMO A Two-Part Study of TB-403 in Pediatric Subjects with Relapsed or Refractory Medulloblastoma, Neuroblastoma, Ewing Sarcoma, or Alveolar Rhabdomyosarcoma Renal Young Adult Patients with Previously Treated Solid Tumors - Wims Tumor Molecular-Guided Therapy for the Treatment of Patients with Relapsed and Refractory Childhood Cancers Eligible Diganoses: Wilms tumor, Renal Cell Carcinoma, Malignant Rhabdoid Tumor and Clear Cell Sarcoma Page 4 of 6

5 Sarcoma/Rhabdomyosaroma/Osteosarcoma/Ewing's Sarcoma AEWS1031 temporarily closed to accrual AEWS1221 AOST1321 A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# , IND# ) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma Phase II Study of Denosumab, a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma AOST1421 temporarily closed to accrual ARST1321 CL PTL 121 temporarily closed to accrual NMTRC ONC Phase II Study of Human-Mouse Chimeric Anti-Disialoganglioside Monoclonal Antibody ch14.18 in Combination with Sargramostim (GM-CSF) in Patients with Recurrent Osteosarcoma Pazopanib Neoadjuvant Trial In Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# , IND# ) Molecular-Guided Therapy for the Treatment of Patients with Relapsed and Refractory Childhood Cancers - Rhabdomyosarcoma and Non rhabdomyosarcoma, Ewings Sarcoma and Osteosarcoma A two-part Phase IIb Trial of Vigil (bi-shrna furin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing s Sarcoma A Two-Part Study of TB-403 in Pediatric Subjects with Relapsed or Refractory Medulloblastoma, Neuroblastoma, Ewing Sarcoma, or Alveolar Rhabdomyosarcoma POETIC G A Phase I/II Multicenter, Open Label, Dose Escalation Study Of The Safety And Pharmacokinetics Of Cobimetinib In Pediatric And Young Adult Patients With Previously Treated Solid Tumors Eligible Diagnoses: Embryonal Rhabdomyosarcoma, other Non-Rhabdomyosarcoma Soft Tissue Sarcomas, and Malignant Rhabdoid Tumors Young Adult Patients with Previously Treated Solid Tumors Eligible Diagnoses: Malignant Rhabdoid Tumor Page 5 of 6

6 Solid Tumors ADVL1322 A Phase II Trial of Pazopanib NSC# , IND# in Children with Refractory Solid Tumors POETIC G POETIC Young Adult Patients with Previously Treated Solid Tumors Eligible Diagnoses: Malignant Rhabdoid Tumor A Phase I/II Multicenter, Open Label, Dose Escalation Study Of The Safety And Pharmacokinetics Of Cobimetinib In Pediatric And Young Adult Patients With Previously Treated Solid Tumors Phase I Study of Carfilzomib in Combination with Cyclophosphamide and Etoposide for Children with Relapsed and Refractory Solid Tumors and Leukemias Pending Studies (check on availability) ARST1431 Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating with Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus in Patients with Intermediate Risk (IR) Rhabdomyosarcoma (RMS) AALL15P1 A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine to Chemotherapy in Infants with Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement Page 6 of 6

CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of )

CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of ) Leukemia AALL0932 closed after Induction CURRENTLY ENROLLING ONCOLOGY TREATMENT STUDIES (as of 10.10.2017) Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized

More information

PEDIATRIC. BRAIN ACNS 0332: Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a COMPANION STUDIES

PEDIATRIC. BRAIN ACNS 0332: Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a COMPANION STUDIES PEDIATRIC BRAIN ACNS 0332: Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in other than Average Risk Medulloblastoma/PNET Patients. https://clinicaltrials.gov/ct2/show/nct00392327?term=0332&rank=6

More information

Contacts. Catherine Aftandilian, MD, MS Gary Dahl, MD Norman Lacayo, MD. Allison Pribnow, MD Sheri Spunt, MD, MBA

Contacts. Catherine Aftandilian, MD, MS Gary Dahl, MD Norman Lacayo, MD. Allison Pribnow, MD Sheri Spunt, MD, MBA and Clinical Trials: Hematology, Oncology, and Stem Cell Transplantation Contacts General Inquiries: Oncology Christina Baggott, RN, PhD General Inquiries: Hematology Elaine Macasiray, RN AML, ALL Catherine

More information

Contacts. Catherine Aftandilian, MD, MS Norman Lacayo, MD Gary Dahl, MD. Sheri Spunt, MD, MBA. Crystal Mackall, MD Kara Davis, DO

Contacts. Catherine Aftandilian, MD, MS Norman Lacayo, MD Gary Dahl, MD. Sheri Spunt, MD, MBA. Crystal Mackall, MD Kara Davis, DO and Clinical Trials: Hematology, Oncology, and Stem Cell Transplantation Contacts General Inquiries Baggott, RN, PhD AML, ALL Bone and Soft Tissue Sarcomas, Renal Tumors Catherine Aftandilian, MD, MS,

More information

Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group)

Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group) Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group) January 2013 The NCIN is a UK-wide initiative, working to drive improvements in standards of cancer care and clinical outcomes by improving

More information

Hem/Onc/BMT Open and Enrolling Clinical Trials

Hem/Onc/BMT Open and Enrolling Clinical Trials Hem/Onc/BMT Open and Enrolling Clinical Trials PROTOCOL ID DISEASE PROTOCOL TITLE PI ELIGIBILITY CRITERIA Pfizer Apixaban DVT Apixaban B0661037, A Randomized, Open-Label, Active Controlled, Safety and

More information

Methoden / Methods inc. ICCC-3 105

Methoden / Methods inc. ICCC-3 105 Methoden / Methods inc. ICCC-3 105 Internationale Klassifikation der Krebserkrankungen bei Kindern (ICCC-3) Zuordnung von ICD-O-3-Codes für Morphologie und Topographie zu diagnostischen Kategorien International

More information

An international clinical program for the diagnosis and treatment of children, adolescents and young adults with ependymoma

An international clinical program for the diagnosis and treatment of children, adolescents and young adults with ependymoma This list covers the Principal Treatment Centre (Alder Hey) and POSCUs including community services. It covers solid tumour oncology and haemato-oncology clinical management protocols and agreed chemotherapy

More information

Open / Closed to Recruitment. POSCU Involvement. Diagnosis Trial Oral Chemo Protocol Title Bone

Open / Closed to Recruitment. POSCU Involvement. Diagnosis Trial Oral Chemo Protocol Title Bone This list covers the Principal Treatment Centre (Alder Hey) and POSCUs including community services. It covers solid tumour oncology and haemato oncology clinical management protocols and agreed chemotherapy

More information

Table 7: PBTC Protocols [ ] Protocol Title Strata Status Neuroimaging Objective/Test

Table 7: PBTC Protocols [ ] Protocol Title Strata Status Neuroimaging Objective/Test Table 7: PBTC Protocols [001 009] Protocol Title Strata Status Neuroimaging Objective/Test PBTC-001 PBTC-002 PBTC-003 PBTC-004 PBTC-005 PBTC-006 PBTC-007 PBTC-009 A Pilot of Systemic and Intrathecal Chemotherapy

More information

Protocol Abstract and Schema

Protocol Abstract and Schema Protocol Abstract and Schema A Phase I Trial of p28 (NSC745104), a Non-HDM2 mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive CNS tumors Description and

More information

TARGETED THERAPY FOR CHILDHOOD CANCERS

TARGETED THERAPY FOR CHILDHOOD CANCERS TARGETED THERAPY FOR CHILDHOOD CANCERS AZIZA SHAD, MD AMEY DISTINGUISHED PROFESSOR OF PEDIATRIC HEMATOLOGY ONCOLOGY, BLOOD AND MARROW TRANSPLANTATION LOMBARDI CANCER CENTER GEORGETOWN UNIVERSITY HOSPITAL

More information

Introduction to Pediatric Neoplasms

Introduction to Pediatric Neoplasms Introduction to Pediatric Neoplasms F C D S E D U C A T I O N A L W E B C A S T S E R I E S S T E V E N P E A C E, B S, C T R / M A Y R A E S P I N O, B A, R H I T, C T R J A N U A R Y 1 7, 2 0 1 3 1 Program

More information

1/15/2013. Introduction to Pediatric Neoplasms. Program Outline. Introduction

1/15/2013. Introduction to Pediatric Neoplasms. Program Outline. Introduction Introduction to Pediatric Neoplasms F C D S E D U C A TI O N A L WE B C A S T S E R I E S ST E VE N P E A C E, B S, C T R / MA Y R A E SP I N O, B A, R H I T, C T R J A N U A R Y 1 7, 2 0 1 3 1 Program

More information

ASSESSMENT OF THE PAEDIATRIC NEEDS CHEMOTHERAPY PRODUCTS (PART I) DISCLAIMER

ASSESSMENT OF THE PAEDIATRIC NEEDS CHEMOTHERAPY PRODUCTS (PART I) DISCLAIMER European Medicines Agency Evaluation of Medicines for Human Use London, September 2006 Doc. Ref.: EMEA/384641/2006 ASSESSMENT OF THE PAEDIATRIC NEEDS CHEMOTHERAPY PRODUCTS (PART I) DISCLAIMER The Paediatric

More information

Title Cancer Drug Phase Status

Title Cancer Drug Phase Status Clinical Trial Identifier Title Cancer Drug Phase Status NCT01164995 Study With Wee-1 Inhibitor MK-1775 and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer Epithelial Ovarian Cancer

More information

CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL

CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL 1. Study title: Subsequent neoplasms among survivors of childhood cancer not previously treated with radiation 2. Working group and investigators:

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cns_embryonal_tumors

More information

Our Clinical Trials. Oncology

Our Clinical Trials. Oncology Our Clinical Trials Oncology ANGIOGENESIS Trebananib (AMG 86) (angiopoietin inhibitor) ANTIBODY DRUG CONJUGATE, continued AMG 595 (anti-egfrviii) Trebananib With Paclitaxel and Trastuzumab or Capecitabine

More information

Diagnosis Place of delivery Proforma

Diagnosis Place of delivery Proforma STCYPCNG List of chemotherapy regimens Day Localised Unresectable neuroblastoma (CCLG guidelines) Carbo-Etoposide Etoposide CADO Doxorubin, Vincristine Irinotecan, Irinotecan-TMZ temozolomide Localised

More information

Childhood cancer registration in England: 2015 to 2016

Childhood cancer registration in England: 2015 to 2016 Childhood cancer registration in England: 2015 to 2016 Report on behalf of the Children, Teenagers and Young Adults Site Specific Clinical Reference Group, National Cancer Registration and Analysis Service

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Solid Tumors of File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_solid_tumors_childhood

More information

Active Cancer Studies by Approval Date For additional information on any one of these studies contact the Lancaster General Cancer Center

Active Cancer Studies by Approval Date For additional information on any one of these studies contact the Lancaster General Cancer Center Active Cancer Studies by Approval Date For additional information on any one of these studies contact the Lancaster General Cancer Center 717-544-3113 PROTOCOL NO STUDY TITLE PRINCIPAL INVESTIGATOR ECOG

More information

CLINICAL TRIALS ACC. Jul 2016

CLINICAL TRIALS ACC. Jul 2016 CLINICAL TRIALS ACC Jul 2016 Glioblastoma BRAIN A071102 A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation

More information

Open Trials as of end of March 2016

Open Trials as of end of March 2016 EORTC 10085 PRO EORTC 10085 prospective part, Clinical and biological characterization of Male Breast Cancer: an international EORTC, BIG and NABCG inter study 30 30-Jun-2016 estelle.cassoly@sakk.ch IBCSG

More information

Commissioning policies agreed by PCTs in Yorkshire and the Humber at Board meeting of YH SCG on December

Commissioning policies agreed by PCTs in Yorkshire and the Humber at Board meeting of YH SCG on December Commissioning policies agreed by PCTs in Yorkshire and the Humber at Board meeting of YH SCG on December 17 2010. 32/10 Imatinib for gastrointestinal stromal tumours (unresectable/metastatic) (update on

More information

5/8/2015. Disclosures. Personalized Medicine & Pediatric Oncology: Is the Future Here Yet? Objectives

5/8/2015. Disclosures. Personalized Medicine & Pediatric Oncology: Is the Future Here Yet? Objectives Disclosures Personalized Medicine & Pediatric Oncology: Is the Future Here Yet? Richard Drachtman, MD NJAAP Annual Conference May 13, 2015 Research Support: Mast, Astra Zeneca, Jazz, Novartis, Pfizer Objectives

More information

CLIC Sargent Eligibility Criteria

CLIC Sargent Eligibility Criteria 1 Eligibility Criteria DOCUMENT GOVERNANCE: Eligibility criteria Produced by J. Hawkins & Grants Team Sponsored by Dara de Burca Version Approval by Executive Team 10 th June 2014 Board of Trustees 3 rd

More information

Radiation Oncology Study Guide

Radiation Oncology Study Guide Radiation Oncology Study Guide For the Initial CertificationQualifying (Computer-Based) Examination General and Radiation Oncology This examination is designed to assess your understanding of the entire

More information

CancerPACT Cancer Patients Alliance for Clinical Trials

CancerPACT Cancer Patients Alliance for Clinical Trials TM CancerPACT Cancer Patients Alliance for Clinical Trials Listing of Cancer Clinical Trials in the Sacramento Area Summer 2008 I. Solid Tumors 1. Breast p.1 2. Central Nervous System p.3 3. Gastrointestinal

More information

Pediatric Oncology. Vlad Radulescu, MD

Pediatric Oncology. Vlad Radulescu, MD Pediatric Oncology Vlad Radulescu, MD Objectives Review the epidemiology of childhood cancer Discuss the presenting signs and symptoms, general treatment principles and overall prognosis of the most common

More information

Xerocept for Control of Tumor or Radiation Mediated Swelling /I-II Mark W. Kieran, MD, PhD

Xerocept for Control of Tumor or Radiation Mediated Swelling /I-II Mark W. Kieran, MD, PhD Treatment Area Study Name ID Number/ Phase BRAIN TUMORS Brain Tumor Imaging Recurrent Brain Tumors A Pilot Non-Therapeutic Neuro-Imaging Study of 18F-FLT in Pediatric Patients with Newly Diagnosed Central

More information

National Cancer Drugs Fund List - Approved

National Cancer Drugs Fund List - Approved National Cancer Drugs Fund List - Approved DRUG Abiraterone Aflibercet Albumin Bound Paclitaxel Axitinib CDF INDICATION (EXCLUDING APPROVED CRITERIA ) Metastatic Prostate Cancer Metastatic Colorectal Cancer

More information

Protocol Abstract and Schema

Protocol Abstract and Schema Protocol Abstract and Schema A Molecular Biology and Phase II Study of Imetelstat (GRN163L) in Children with Recurrent High-Grade Glioma, Ependymoma, Medulloblastoma/Primitive Neuroectodermal Tumor and

More information

FAST FACTS Eligibility Reviewed and Verified By MD/DO/RN/LPN/CRA Date MD/DO/RN/LPN/CRA Date Consent Version Dated

FAST FACTS Eligibility Reviewed and Verified By MD/DO/RN/LPN/CRA Date MD/DO/RN/LPN/CRA Date Consent Version Dated Page 1 of 5 COG-AEWS1221: Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly

More information

The Texas Pediatric PDX Core. Peter J. Houghton, Ph.D., Director Greehey Children s Cancer Research Institute UT Health Science Center San Antonio

The Texas Pediatric PDX Core. Peter J. Houghton, Ph.D., Director Greehey Children s Cancer Research Institute UT Health Science Center San Antonio The Texas Pediatric PDX Core Peter J. Houghton, Ph.D., Director Greehey Children s Cancer Research Institute UT Health Science Center San Antonio GOALS To successfully heterograft and propagate 200-250

More information

RMS, RMS. (rhabdomyosarcoma,rms) (Intergroup RMS Study Group,IRSG) ( European Pediatric soft tissue sarcomas study group,epssg)

RMS, RMS. (rhabdomyosarcoma,rms) (Intergroup RMS Study Group,IRSG) ( European Pediatric soft tissue sarcomas study group,epssg) 724 2017 10 55 10 Chin J Pediatr, October 2017, Vol.55, No.10 ( CCCG-RMS-2016) (rhabdomyosarcoma,rms), 6.5% [1-3], RMS,, (Intergroup RMS Study Group,IRSG) ( European Pediatric soft tissue sarcomas study

More information

Advances in paediatric cancer treatment

Advances in paediatric cancer treatment Review Article Advances in paediatric cancer treatment Federica Saletta 1,2, Michaela S. Seng 2, Loretta M.S. Lau 1,2,3 1 Children s Cancer Research Unit, Kid s Research Institute, The Children s Hospital

More information

The medical team consists of 2 Hemato-Oncologists pediatrician and 6 Hematologists pediatricians.

The medical team consists of 2 Hemato-Oncologists pediatrician and 6 Hematologists pediatricians. Dr. Robert Reid Cabral Children s Hospital Dominican Republic Brief Description of the Hematology-Oncology Service Palliative Care Pilot Program and Metronomic Therapy Dr. Robert Reid Cabral Children's

More information

Paediatric Cancer. Brain. Germ Cell. Embryonic Tumour. Haematology Malignancies. Open. In Development. In Development. Open. Open.

Paediatric Cancer. Brain. Germ Cell. Embryonic Tumour. Haematology Malignancies. Open. In Development. In Development. Open. Open. Paediatric Cancer Brain LGG2: Cooperative multicenter study for children and adolescents with Low Grade Glioma GD2: A Phase I/II dose schdule finding study of CH14.18/CHO continuous infusion combined wugt

More information

Childhood Cancer Statistics, England Annual report 2018

Childhood Cancer Statistics, England Annual report 2018 Childhood Cancer Statistics, England Annual report 2018 Report on behalf of the Children, Teenagers and Young Adults Expert Advisory Group, National Cancer Registration and Analysis Service 1 About Public

More information

Selected Protocols for the Treatment of Pediatric Cancer and Blood Disorders

Selected Protocols for the Treatment of Pediatric Cancer and Blood Disorders Selected Protocols for the Treatment of Pediatric Cancer and Blood Disorders This listing changes frequently. It also does not include most of our Children s Oncology Group (COG) trials. We are part of

More information

1. Background & Scope 3

1. Background & Scope 3 Birmingham Children s Hospital Primary treatment centre (PTC) list of protocols and guidelines which contain approved cytotoxic chemotherapy regimens Updated 9 th June 2016 (Jason Patel) Contents 1. Background

More information

Declining Childhood and Adolescent Cancer Mortality

Declining Childhood and Adolescent Cancer Mortality Declining Childhood and Adolescent Cancer Mortality Malcolm A. Smith, MD, PhD 1 ; Sean F. Altekruse, DVM, PhD 2 ; Peter C. Adamson, MD 3 ; Gregory H. Reaman, MD 4 ; and Nita L. Seibel, MD 1 BACKGROUND:

More information

Proceedings of Congress

Proceedings of Congress HK J Paediatr (new series) 2012;17:123-129 Proceedings of Congress 2011 Annual Scientific Meeting: Hong Kong Paediatric Haematology and Oncology Study Group 26 March 2011 Acute Lymphoblastic Leukaemia

More information

Effective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide,

Effective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide, Ewing Tumor Perez Ewing tumor is the second most common primary tumor of bone in childhood, and also occurs in soft tissues Ewing tumor is uncommon before 8 years of age and after 25 years of age In the

More information

Paediatric Cancer. Brain. Germ Cell. Embryonic Tumour. Haematology Malignancies

Paediatric Cancer. Brain. Germ Cell. Embryonic Tumour. Haematology Malignancies Paediatric Cancer Brain SIOP Ependymoma II; An International Multi Centre Clinical Program for the ependymoma@trials.bham.ac.uk diagnosis and treatment of children, adolescents and young adults with Ependymoma

More information

RARE TUMORS OF INFANCY. RAJKUMAR VENKATRAMANI, MD, MS Director, Rare Tumors Program, Texas Children s Hospital

RARE TUMORS OF INFANCY. RAJKUMAR VENKATRAMANI, MD, MS Director, Rare Tumors Program, Texas Children s Hospital RARE TUMORS OF INFANCY RAJKUMAR VENKATRAMANI, MD, MS Director, Rare Tumors Program, Texas Children s Hospital OBJECTIVES Review the epidemiology and clinical presentation of soft tissue sarcomas in infancy.

More information

OVERVIEW OF COMMENTS RECEIVED ON LIST OF PAEDIATRIC NEEDS ONCOLOGY I (CYTOTOXIC THERAPY)

OVERVIEW OF COMMENTS RECEIVED ON LIST OF PAEDIATRIC NEEDS ONCOLOGY I (CYTOTOXIC THERAPY) European Medicines Agency Evaluation of Medicines for Human Use London, September 2006 Doc. Ref. OVERVIEW OF COMMENTS RECEIVED ON LIST OF PAEDIATRIC NEEDS ONCOLOGY I (CYTOTOXIC THERAPY) Table 1: Organisations

More information

Significant Papers in Pediatric Oncology: Phase I Studies Current Status and Future Directions

Significant Papers in Pediatric Oncology: Phase I Studies Current Status and Future Directions Significant Papers in Pediatric Oncology: Phase I Studies Current Status and Future Directions Susannah E. Koontz, PharmD, BCOP Clinical Pharmacy & Education Consultant Pediatric Hematology/Oncology and

More information

Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma

Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma Policy Number: Original Effective Date: MM.07.013 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO 02/24/2012

More information

Open and Pending Trials Listing For Arizona Oncology Associates P.C. HOPE Division/ Tucson, Arizona

Open and Pending Trials Listing For Arizona Oncology Associates P.C. HOPE Division/ Tucson, Arizona Open and Pending Trials Listing For Arizona Oncology Associates P.C. HOPE Division/ Tucson, Arizona Solid Tumor: USON 15180 / A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab

More information

Keytruda (pembrolizumab)

Keytruda (pembrolizumab) Keytruda (pembrolizumab) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 10/01/2015 Current Effective Date: 07/24/2017TBD03/01/2018 POLICY A. INDICATIONS The

More information

SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS

SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib,

More information

TUESDAY, 18th OCTOBER, 2016 / DAY -2

TUESDAY, 18th OCTOBER, 2016 / DAY -2 Legend: Keynote Educational PODC Symposium Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite Symposium SIOPe GA SIOP ABM Late

More information

Product Visual Guide

Product Visual Guide Product Visual Guide Teamwork A team with an unflinching faith in one another is one of our core strength. Excellence Achieving excellence is not the end result, we begin with excelling in any endeavor.

More information

TUESDAY, 18th OCTOBER, 2016 / DAY -2. THE SPENCER HOTEL Hall A Hall B (St. Lukes Hospital)

TUESDAY, 18th OCTOBER, 2016 / DAY -2. THE SPENCER HOTEL Hall A Hall B (St. Lukes Hospital) Legend: Keynote Educational Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite SIOPe GA SIOP ABM Late Breaker Session Networking

More information

Sarcomas. Living Beyond Cancer A-Z UT Health San Antonio MD Anderson Cancer Center

Sarcomas. Living Beyond Cancer A-Z UT Health San Antonio MD Anderson Cancer Center Sarcomas Living Beyond Cancer A-Z UT Health San Antonio MD Anderson Cancer Center Aaron Sugalski, DO Associate Professor of Pediatric Hematology/Oncology Medical Director, UHS Pediatric Blood and Cancer

More information

Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma

Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma Hematopoietic Stem-Cell Transplantation for CNS Embryonal Tumors and Ependymoma Policy Number: 8.01.28 Last Review: 7/2014 Origination: 7/2002 Next Review: 7/2015 Policy Blue Cross and Blue Shield of Kansas

More information

OPEN TRIALS Accruals counted until 30-April Current Accrual

OPEN TRIALS Accruals counted until 30-April Current Accrual Disease group Breast OPEN TRIALS Trial Title Accrual Target IBCSG 48-14 POSITIVE IBCSG 50-14 OLYMPIA IBCSG 52-15 PALLAS SAKK 21/12 A study evaluating the pregnancy outcomes and safety of interrupting endocrine

More information

CancerPACT Cancer Patients Alliance for Clinical Trials

CancerPACT Cancer Patients Alliance for Clinical Trials TM CancerPACT Cancer Patients Alliance for Clinical Trials Listing of Ongoing Cancer Clinical Trials in the Sacramento Area Winter 2008 I. Solid Tumors 1. Breast p.1 2. Central Nervous System p.2 3. Gastrointestinal

More information

A is for Alive Artwork created by St. Jude patient Asia Age: 11 years Diagnosis: Acute lymphoblastic leukemia

A is for Alive Artwork created by St. Jude patient Asia Age: 11 years Diagnosis: Acute lymphoblastic leukemia A is for Alive Artwork created by St. Jude patient Asia Age: 11 years Diagnosis: Acute lymphoblastic leukemia ALSAC-02268_ABCs_Intranet_Flyers.indd 1 4/22/10 11:50:55 AM B is for Believe Artwork created

More information

Irinotecan and temozolomide in adults with recurrent sarcoma

Irinotecan and temozolomide in adults with recurrent sarcoma ORIGINAL ARTICLE Irinotecan and temozolomide in adults with recurrent sarcoma Phillip S. Blanchette 1, Aaron Lo 2, Pamela Ng 2, Albiruni Razak 3,4, Eitan Amir 4, David Hogg 4, Martin E. Blackstein 3, Abha

More information

CancerPACT Cancer Patients Alliance for Clinical Trials

CancerPACT Cancer Patients Alliance for Clinical Trials TM CancerPACT Cancer Patients Alliance for Clinical Trials Listing of Ongoing Cancer Clinical Trials in the Salinas Valley Winter 2008 I. Solid Tumors 1. Breast p.1 2. Central Nervous System p.2 3. Gastrointestinal

More information

SIOP Europe the European Society for Paediatric Oncology European Network for Cancer Research in Children and Adolescents

SIOP Europe the European Society for Paediatric Oncology European Network for Cancer Research in Children and Adolescents the European Society for Paediatric Oncology encca European Network for Cancer Research in Children and Adolescents EUROPEAN TRAINING PROGRAMME IN PAEDIATRIC HAEMATOLOGY AND ONCOLOGY EUROPEAN BOARD OF

More information

HSHS St. Vincent Hospital Regional Cancer Center Adult Active Study List

HSHS St. Vincent Hospital Regional Cancer Center Adult Active Study List NHLBI-MDS ECOG-A NCT02775383 Blood Disorders-Other The National Myelodysplastic Syndromes (MDS) Study A221101 ALLIANCE NCT01781468 Brain A Phase III Randomized, Double-Blind Placebo Controlled Study of

More information

Pediatric Brain Tumors Pre, Intra & Post Op Evaluation and Management. Timothy M. George, MD, FACS, FAAP

Pediatric Brain Tumors Pre, Intra & Post Op Evaluation and Management. Timothy M. George, MD, FACS, FAAP Pediatric Brain Tumors Pre, Intra & Post Op Evaluation and Management Timothy M. George, MD, FACS, FAAP PEDIATRIC BRAIN TUMORS BACKGROUND: Incidence: Third most common pediatric tumor type (leukemia, neuroblastoma,

More information

Pediatric Cancer in Idaho,

Pediatric Cancer in Idaho, Pediatric Cancer in Idaho, 1996-2006 Although relatively rare in comparison with cancer in older adults, cancer is the second leading cause of death in persons aged 1-14 years. The epidemiology of cancer

More information

Case 1. Maysa Al-Hussaini MD FRCPath

Case 1. Maysa Al-Hussaini MD FRCPath Case 1 Maysa Al-Hussaini MD FRCPath MAYSA King AL-HUSSAINI Hussein Cancer MD Center MRCPATH KING HUSSEIN Amman CANCER Jordan CENTER Clinical history 4 year old boy History of frontal headache, sleepiness.

More information

Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident

Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident Residents: Pediatric residents at the PL3 level Prerequisites: Successful completion or waiver

More information

Histopathological Study and Categorisation of Brain Tumors

Histopathological Study and Categorisation of Brain Tumors Histopathological Study and Categorisation of Brain Tumors Ruchira Wadhwa 1*, Purvi Patel 2, Hansa Goswami 3 1 Third Year Resident, 2 Assistant Professor, 3 Professor and Head, Department of Pathology,

More information

New Surgical Oncology Clinic at Nationwide Children s Hospital

New Surgical Oncology Clinic at Nationwide Children s Hospital Hematology/Oncology & BMT New Surgical Oncology Clinic at Nationwide Children s Hospital This clinic offers convenient, comprehensive care for patients with cancer. Here, in one visit, pediatric patients

More information

RESEARCH COMMUNICATION. Childhood Cancer Incidence and Survival , Thailand: Study from the Thai Pediatric Oncology Group

RESEARCH COMMUNICATION. Childhood Cancer Incidence and Survival , Thailand: Study from the Thai Pediatric Oncology Group Childhood Cancer Incidence and Survival 2003-2005, Thailand RESEARCH COMMUNICATION Childhood Cancer Incidence and Survival 2003-2005, Thailand: Study from the Thai Pediatric Oncology Group Surapon Wiangnon

More information

Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository ( ) for cancer in Teenagers and Young Adults

Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository ( ) for cancer in Teenagers and Young Adults Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository (2007 09) for cancer in Teenagers and Young Adults (TYA) CTYA SSCRG Data quality report on the frequency

More information

CHILDHOOD CANCERS are rare, accounting for less than

CHILDHOOD CANCERS are rare, accounting for less than Regulatory Approvals of Pediatric Oncology Drugs: Previous Experience and New Initiatives By Steven Hirschfeld, Peter T.C. Ho, Malcolm Smith, and Richard Pazdur Purpose: To review the Food and Drug Administration

More information

Site Specific Coding Rules MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS

Site Specific Coding Rules MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS Multiple Primary and Histology Site Specific Coding Rules MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS 1 Prerequisites 2 Completion of Multiple Primary and Histology General Coding Rules 3 There are many ways

More information

Avastin (bevacizumab) DRUG.00028, CG-DRUG-68

Avastin (bevacizumab) DRUG.00028, CG-DRUG-68 Avastin (bevacizumab) DRUG.00028, CG-DRUG-68 Override(s) Prior Authorization Approval Duration 1 year Medications Avastin (bevacizumab) APPROVAL CRITERIA Requests for Avastin (bevacizumab) may be approved

More information

Brain Tumors in Children

Brain Tumors in Children Brain Tumors in Children Michael A. Grotzer University Children s Hospital of Zurich, Switzerland Incidence of Childhood Cancer CNS Tumors Acute lymphoblastic Leukemia Neuroblastoma Non-Hodgkin Lymphoma

More information

Chemotherapy for Childhood Medulloblastoma and Primitive Neuroectodermal Tumors

Chemotherapy for Childhood Medulloblastoma and Primitive Neuroectodermal Tumors Chemotherapy for Childhood and Primitive Neuroectodermal Tumors ROGER J. PACKER, a JONATHAN L. FINLAY b a Department of Neurology, Children s National Medical Center, Washington DC, USA; b Departments

More information

Recommended Timing for Transplant Consultation

Recommended Timing for Transplant Consultation REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org

More information

German Hodgkin Study Group

German Hodgkin Study Group German Hodgkin Study Group Deutsche Hodgkin Studiengruppe Avoiding Relapse of Hodgkin Lymphoma: Have We Moved The Needle? Andreas Engert, MD Chairman, German Hodgkin Study Group University Hospital of

More information

Challenges in studying risk factors for childhood cancer

Challenges in studying risk factors for childhood cancer Challenges in studying risk factors for childhood cancer Julie A. Ross, Ph.D. Professor and Director, Division of Epidemiology & Clinical Research Department of Pediatrics, University of Minnesota & Masonic

More information

The Clinical Research E-News

The Clinical Research E-News Volume 3: ISSUE 5: March 23, 2011 The Clinical Research E-News Now Open: CALGB 90802, Randomized Phase III trial comparing everolimus plus placebo versus everolimus plus bevacizumab for advanced renal

More information

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,

More information

The Clinical Research E-News

The Clinical Research E-News Volume 2: ISSUE 5: March 10, 2010 The Clinical Research E-News Coming soon: AZ1071, A Phase II Study Evaluating the Role of Sentinel Lymph Node Surgery and Axillary Lymph Node Dissection Following Preoperative

More information

Background. Paediatric cancer. Leukaemia

Background. Paediatric cancer. Leukaemia 66 9. Paediatric cancer Background Radiotherapy (RT) is an important modality of therapy in the local control of paediatric malignancies and the majority of paediatric tumours are radiosensitive. However,

More information

Treatment of Paediatric Cancers in Hong Kong: An Interim Report

Treatment of Paediatric Cancers in Hong Kong: An Interim Report HK J Paediatr (new series) 2001;6:110-115 in Hong Kong: An Interim Report CK LI, GCF CHAN, KW CHIK, SY HA, YL LAU, ACW LEE, CY LEE, CK LI, SC LING, CW LUK, MMK SHING, HL YUEN, PMP YUEN Abstract Key words

More information

HSHS St. Vincent Hospital Regional Cancer Center Adult Active Study List

HSHS St. Vincent Hospital Regional Cancer Center Adult Active Study List A031501 ALLIANCE NCT03244384 Bladder Phase III Randomized Adjuvant study of MK-3475 (Pembrolizumab) in muscle invasive and locally advanced urothelial carcinoma (AMBASSADOR) Versus Observation NHLBI-MDS

More information

Protocol Abstract and Schema

Protocol Abstract and Schema Protocol Abstract and Schema Phase II study of Bevacizumab plus Irinotecan (Camptosar ) in Children with Recurrent, Progressive, or Refractory Malignant Gliomas, Diffuse/Intrinsic Brain Stem Gliomas, Medulloblastomas,

More information

Bone Marrow Transplant Gynecologic Immunotherapy Phase 1. Breast Head & Neck Melanoma/Skin Sarcoma

Bone Marrow Transplant Gynecologic Immunotherapy Phase 1. Breast Head & Neck Melanoma/Skin Sarcoma Karmanos offers clinical trials for many different forms of cancer. Below are the most current clinical trials open to new participants as of this publication's issue date. If you have any questions regarding

More information

Bone Marrow Transplant Gynecologic Immunotherapy Phase 1. Breast Head & Neck Melanoma/Skin Sarcoma

Bone Marrow Transplant Gynecologic Immunotherapy Phase 1. Breast Head & Neck Melanoma/Skin Sarcoma Karmanos offers clinical trials for many different forms of cancer. Below are the most current clinical trials open to new participants as of this publication's issue date. If you have any questions regarding

More information

SOLID TUMOURS IN CHILDHOOD

SOLID TUMOURS IN CHILDHOOD SOLID TUMOURS IN CHILDHOOD Fareed Omar Paediatric Oncology Steve Biko Academic hospital Introduction 1 Introduction Lymphomas and Leukemias make up about 40% of all childhood Cancers (Systemic cancers)

More information

Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ )

Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ ) 1 di 8 04/03/2017 07.31 NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute

More information

SHEDDING A LITTLE LIGHT ON THE BIGGER PROBLEM

SHEDDING A LITTLE LIGHT ON THE BIGGER PROBLEM NationalPCF.org SHEDDING A LITTLE LIGHT ON THE BIGGER PROBLEM 1.7 MILLION NEW CANCER CASES EVERY YEAR 600,000 PEOPLE WILL DIE More than of those who survive childhood cancer will have a significant health

More information

The IMI2 ITCC-P4 Paediatric Preclinical Proof-of-Concept Platform ACCELERATE 2018 Grant Agreement No ITCC-P4

The IMI2 ITCC-P4 Paediatric Preclinical Proof-of-Concept Platform ACCELERATE 2018 Grant Agreement No ITCC-P4 The IMI2 ITCC-P4 Paediatric Preclinical Proof-of-Concept Platform ACCELERATE 2018 Grant Agreement No 116064 ITCC-P4 Louis Stancato, Eli Lilly and Company On behalf of the ITCC-P4 Leadership Team Gilles

More information

The Clinical Research E-News

The Clinical Research E-News Volume 2: ISSUE 10: May 19, 2010 The Clinical Research E-News Coming soon: NSABP FC-6, A Phase II Study to Determine the Surgical Conversion Rate in Patients Receiving Neoadjuvant mfolfox7 Plus Cetuximab

More information

CCSS Therapy Working Group

CCSS Therapy Working Group CCSS Therapy Working Group Temporally limited, but critical to all aims of the CCSS Immediate tasks: Review and advise on current CCSS MRAF Drugs (doses and exposure) XRT Surgery Develop plans for quality

More information

Clinical Policy: Temozolomide (Temodar) Reference Number: ERX.SPA.138 Effective Date:

Clinical Policy: Temozolomide (Temodar) Reference Number: ERX.SPA.138 Effective Date: Clinical Policy: (Temodar) Reference Number: ERX.SPA.138 Effective Date: 03.01.14 Last Review Date: 05.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

For Health Professionals Who Care For Cancer Patients EDITOR S CHOICE

For Health Professionals Who Care For Cancer Patients EDITOR S CHOICE Inside This Issue: For Health Professionals Who Care For Cancer s March 2019 Vol. 22 No. 3 Editor s Choice New Programs: Rituximab Protocols in CLL/SLL Updated (LYCLLBENDR, LYCLLCHLR, LYCLLCVPR, LYCLLFLUDR,

More information

6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June 2016 Berlin, Germany. Chairs: A. Eggert, DE B. Morland, UK R.

6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June 2016 Berlin, Germany. Chairs: A. Eggert, DE B. Morland, UK R. MASTERCLASS 6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY Held with the support of 11-16 June 2016 Berlin, Germany Chairs: A. Eggert, DE B. Morland, UK R. Riccardi, IT INTRODUCTION ESO and SIOP-Europe

More information